COVID-19 Testing Fraud Exposed: Zishan Alvi's $14 Million Deception

Tuesday, 1 October 2024, 09:41

COVID-19 testing fraud has been spotlighted as lab owner Zishan Alvi pleads guilty, revealing a scheme worth $14 million. Alvi was accused of billing for tests not conducted.
Newsweek
COVID-19 Testing Fraud Exposed: Zishan Alvi's $14 Million Deception

COVID-19 Testing Fraud Scheme Uncovered

On September 30, Zishan Alvi, 45, an Illinois laboratory owner, pleaded guilty to wire fraud in connection with a fraudulent COVID-19 testing scheme that bilked the government for $14 million. From February 2021 to February 2022, Alvi allegedly made fraudulent claims to the Department of Health and Human Services' Health Resources and Services Administration (HRSA) for tests that were never conducted.

Exorbitant Claims and Investigations

  • The HRSA reportedly processed over $83 million in payments to Alvi for fabricated COVID-19 tests.
  • Alvi's laboratory provided negative results for samples that were either not tested or inconclusive.
  • The federal investigation, led by the FBI and HHS-OIG, continues as the case unfolds.

According to the indictment, Alvi's lab claimed to offer PCR tests and rapid antigen tests delivering results in 15 minutes. Allegedly, he enrolled in the HRSA Uninsured Program, designed to cover COVID-19 testing for those without health insurance. After misappropriating HRSA funds, Alvi used the money to buy luxury vehicles and invest in cryptocurrency.

Legal Repercussions

  1. Indicted on ten counts of wire fraud and one count of theft of government funds.
  2. Pleaded guilty to one charge of wire fraud.
  3. Sentencing scheduled for February 7, 2025; faces up to 20 years in prison.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe